August 15, 2012
Altura Medical Names G. Ray Martin President and CEO
Early-stage medical-device manufacturer Altura Medical Inc. has appointed G. Ray Martin as its president and chief executive and as a member of its board.
Dr. Martin previously was president and CEO of NovoStent Corp. Before that, he was a vice president of business development at Boston Scientific Corp., as well as at TriVascular Inc., which was acquired by Boston Scientific. Before joining TriVascular, Dr. Martin held executive positions at C.R. Bard Inc. and W.L. Gore & Associates Inc. where he led development of various stent graft devices, Altura said in a news release.
San Clemente, Calif.-based Altura was founded in 2008 and is focused on devices and methods for treatment of aneurysms in the arterial vascular system. With a clinical trial started in June 2011, Altura said it will expand clinical evaluations to support regulatory approval and commercialization.
Major investors include Advanced Technology Ventures, New Leaf Venture Partners and SV Life Sciences Advisers. In 2010, the company secured $20 million in Series A financing.